UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Gladstone Institutional Advisory LLC

Gladstone Institutional Advisory LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 13,863 shares of the healthcare conglomerate’s stock after buying an additional 175 shares during the period. Gladstone Institutional Advisory LLC’s holdings in UnitedHealth Group were worth $7,013,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently made changes to their positions in UNH. AMF Tjanstepension AB boosted its holdings in shares of UnitedHealth Group by 88.0% in the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after acquiring an additional 121,180 shares during the last quarter. Hudson Value Partners LLC grew its position in UnitedHealth Group by 8.3% during the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after purchasing an additional 82 shares during the period. Wealth Group Ltd. lifted its holdings in shares of UnitedHealth Group by 4.0% in the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after buying an additional 68 shares during the period. Creative Planning raised its position in UnitedHealth Group by 11.0% during the third quarter. Creative Planning now owns 212,295 shares of the healthcare conglomerate’s stock valued at $123,025,000 after acquiring an additional 21,114 shares in the last quarter. Finally, Iams Wealth Management LLC boosted its position in UnitedHealth Group by 9.7% in the 3rd quarter. Iams Wealth Management LLC now owns 2,147 shares of the healthcare conglomerate’s stock worth $1,255,000 after purchasing an additional 189 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. Morgan Stanley reduced their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Up 0.1 %

Shares of UNH opened at $533.99 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $491.42 billion, a P/E ratio of 34.45, a P/E/G ratio of 1.45 and a beta of 0.61. The firm has a 50-day moving average price of $527.67 and a 200 day moving average price of $564.22. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the firm posted $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.